Showing 621 - 640 results of 1,767 for search '(( 100 (teer OR per) decrease ) OR ( 10 ((we decrease) OR (((a decrease) OR (mean decrease)))) ))*', query time: 0.15s Refine Results
  1. 621
  2. 622

    CLINICAL AND ECONOMIC IMPACT OF GENETIC AND NON-GENETIC FACTORS ON INR NORMALIZATION IN PRE-OPERATIVE MANAGEMENT OF WARFARIN PATIENTS by ELJILANY, ISLAM AHMED SAYED AHMED

    Published 2021
    “…To optimize the period of preprocedural warfarin interruption to decrease the incidence of bleeding in case of bridging and the incidence of thromboembolism in case of non-bridging, a study was conducted to determine the influence of CYP2C9, VKORC1, CYP4F2, FII, and FVII genetic polymorphisms and non-genetic factors on INR decline in a cohort of Arabs undergoing a procedure that requires warfarin interruption and developing an algorithm to tailor the duration of warfarin interruption before the procedure. …”
    Get full text
  3. 623
  4. 624

    Wind energy potential along the onshore and offshore Qatar by Mohammed, Aboobacker Valliyil

    Published 2020
    “…cant increase or decrease of wind power around Qatar in the last 40 years in most of the locations, while there is a slight decreasing trend in the o?…”
    Get full text
    Get full text
  5. 625
  6. 626

    Absorption of CO2 in aqueous blend of methyldiethanolamine and arginine by Talkhan, Ahmed Gomaa

    Published 2020
    “…The study was carried out at different mixing ratios of MDEA and Arg at a total concentration of 2 moles per litre. The CO2 partial pressure varied from about 10 to 100 kPa, and the temperature varied from 293 K to 323 K. …”
    Get full text
    Get full text
  7. 627
  8. 628
  9. 629
  10. 630
  11. 631
  12. 632
  13. 633
  14. 634

    Understanding the mechanisms mediating cardio-renal benefit of empagliflozin in type 2 diabetes mellitus by Dimitrios, Patoulias

    Published 2023
    “…They have demonstrated1 that empagliflozin treatment resulted in a significant decrease in pulse pressure (PP), mean arterial pressure (MAP) and cardiac workload, compared with placebo; at week 12, placebo-adjusted mean changes from baseline were − 2.5 mmHg for PP, − 2.2 mmHg for MAP and − 315 mmHg x beats per minute (bpm) for cardiac workload (p < 0.0001 for all). …”
    Get full text
    Get full text
    Get full text
  15. 635
  16. 636
  17. 637
  18. 638
  19. 639
  20. 640